[Use of prognostic knowledge in the planning and analysis of randomized therapeutic trials].

Abstract:

:For most diseases, one observes great variability in clinical course and response to therapy which should be taken into account in the design and the analysis of clinical trials. Eligibility criteria and stratified randomization use prognostic knowledge. A suitable analysis of randomized studies includes: (1) checking treatment effect groups for comparability, (2) adjustment of treatment effect by stratifying or modeling to account for any imbalances in prognostic factors and to increase the precision of the treatment comparison by reducing random variation, (3) looking for treatment-covariate interactions suggesting that response to treatment depends on patients' characteristics. Tests for interaction should be interpreted with caution in light of medical plausibility; multiple comparisons should be taken into account. Recording information on known prognostic factors in clinical trials is important, as is the continuing search for new ones.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Byar D,Chastang C

subject

Has Abstract

pub_date

1987-01-01 00:00:00

pages

177-84

issue

2

eissn

0007-4551

issn

1769-6917

journal_volume

74

pub_type

杂志文章
  • [Polymorphism in HLA and KIR genes and the impact on hematopoietic stem cell transplantation outcomes and unrelated donor selection: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the c...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引

    doi:10.1016/j.bulcan.2016.09.005

    authors: Dubois V,Brignier A,Elsermans V,Gagne K,Kennel A,Pedron B,Picard C,Ravinet A,Varlet P,Cesbron A,Delbos F,Yakoub-Agha I,Loiseau P

    更新日期:2016-11-01 00:00:00

  • [Ataxia telangiectasia: what impact in clinical oncology?].

    abstract::Ataxia telangiectasia (AT) is a hereditary disease transmitted in a recessive mode and characterized by chromosomal instability and radiosensitivity. AT patients have a 100-fold higher risk of cancer than the general population. Although AT is a rare disease of which the frequency has been estimated to be 1/40,000, th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Stoppa-Lyonnet D,Aurias A

    更新日期:1992-01-01 00:00:00

  • [Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].

    abstract:CONTEXT:The "Standards, Options and Recommendations" (SOR) collaborative project was initiated in 1993 by the Federation of the French Cancer Centres (FNCLCC), with the 20 French Regional Cancer Centres, several French public university and general hospitals, as well as private clinics and medical specialty societies. ...

    journal_title:Bulletin du cancer

    pub_type: 指南,杂志文章,实务指引

    doi:

    authors: Denoux Y,Blanc-Vincent MP,Simony-Lafontaine Jl,Verriele-Beurrier V,Briffod M,Voigt JJ

    更新日期:2002-04-01 00:00:00

  • [Radioimmunotherapy of follicular lymphoma: a step towards cure?].

    abstract::Advanced stage follicular lymphoma is incurable by conventional treatment. Important progress has been observed with the development of new therapies based on monoclonal antibodies and on the use of radioimmunotherapy (RIT) in the treatment of non-Hodgkin lymphomas (NHL). Rituximab in combination with chemotherapy in ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ketterer N,Bischof Delaloye A,Helg C,Luthi F,Buchegger F

    更新日期:2007-09-01 00:00:00

  • [Towards an inventory of oncogenic mutations in cancer].

    abstract::The discovery of oncogenes and tumor suppressors has established the original concept of cancer development based on a cascade of spontaneously occurring somatic mutations. It is now well known that genomes of cancer cells are deeply rearranged and that these rearrangements have devastating consequences on their organ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1200

    authors: Theillet C

    更新日期:2010-11-01 00:00:00

  • [WHO classification of head and neck tumours 2017: Main novelties and update of diagnostic methods].

    abstract::The publication of the new WHO classification of head and neck tumours in 2017 brought major modifications. Especially, a new chapter is dedicated to the oropharynx, focusing on the description of squamous cell carcinoma induced by the virus Human Papilloma Virus (HPV), and new entities of tumors are described in nasa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.04.004

    authors: Sarradin V,Siegfried A,Uro-Coste E,Delord JP

    更新日期:2018-06-01 00:00:00

  • [Patients and the Web].

    abstract::In recent years, Internet has become an indispensable tool for all types of information. Its importance has increased in medicine and particularly in human malignancies. The data issued by the Internet are many and varied sources ranging from official websites to patient's blogs. HIV infection is an infection highly p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1160

    authors: Cluzeau T,Mounier N

    更新日期:2010-10-01 00:00:00

  • [Neurotrophic theories of stress and neurobiology of antidepressants: applications in psycho-oncology].

    abstract::For some years, the concept of stress has been accepted as a reference framework for the study of disturbances of psychological adjustment to cancer. Stress is defined as a state of physiological and psychological < tension > resulting from the interaction between an individual and her environment. Damaging consequenc...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ronson A

    更新日期:2007-05-01 00:00:00

  • Medical practices and cancer care networks: examples in oncology.

    abstract::Understanding medical practices or the whys and wherefores of care decision-making is among the major objectives of medical, economic and sociological research in the current political environment. Although variations of medical practice have long been known to exist, causes and deciding factors remain obscure. This i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Ray-Coquard I,Chauvin F,Lurkin A,Ducimetière F,Jacquin JP,Agostini C,Pouchard I,Meyer B,Farsi F,Castel P,Perrier L,Philip T

    更新日期:2006-02-01 00:00:00

  • [SOR SAVOIR PATIENT Cancer and fatigue. Information dedicated to cancer patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dielenseger P,Dilhuydy JM,Brusco S,Chazot L,Blay JY,Bové B,Colcanap B,Ferrandez JC,Floquet A,Jane Gledhill,Hubert N,Meslier M,Rosman S,Carretier J,Delavigne V,Fervers B,Leichtnam-Dugarin L,Philip T,Standards, Options

    更新日期:2006-12-01 00:00:00

  • Nouvelles perspectives dans l’immunothérapie des cancers.

    abstract:NOVEL PERSPECTIVES IN CANCER IMMUNOTHERAPIES:Š. ...

    journal_title:Bulletin du cancer

    pub_type: 社论

    doi:10.1016/S0007-4551(18)30384-9

    authors: Caux C,Bay JO

    更新日期:2018-12-01 00:00:00

  • 4-methylthio 2-oxobutanoate transaminase: a specific target for antiproliferative agents.

    abstract::We have previously shown that the addition of 4-methylthio-2-oxobutanoate (MTOB) to cultures of methionine dependent neoplastic cells which lack endogenous MTOB restores their capacity to grow in the absence of exogenous methionine. Transition state inhibitors of the MTOB transaminase,responsible for the transaminatio...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Quash G,Roch AM,Charlot C,Chantepie J,Thomas V,Hamedi-Sangsari F,Vila J

    更新日期:2004-04-01 00:00:00

  • [Use of complementary medicine by cancer patients in a French oncology department].

    abstract::The aims of this study was to estimate and describe the reasons of use of complementary medicine in patients with a cancer treated in a French oncology department. An anonymous questionnaire was proposed to patients during treatment or follow-up in an oncology department. It was a descriptive study over 207 questionna...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Träger-Maury S,Tournigand C,Maindrault-Goebel F,Afchain P,de Gramont A,Garcia-Larnicol ML,Gervais H,Louvet C

    更新日期:2007-11-01 00:00:00

  • [Is AP24534 (Ponatinib) the next treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia?].

    abstract::Distinct clinicopathologic acute lymphoblastic leukemia (ALL) entities have been identified, resulting in the adoption of risk-oriented treatment approaches. In Philadelphia chromosome-positive (Ph(+)) ALL, the optimal treatment requires the addition of BCR-ABL tyrosine kinase inhibitors, as imatinib. However, the out...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1390

    authors: Thomas X

    更新日期:2011-07-01 00:00:00

  • [Multiple brain metastases after breast cancer and their radiotherapy management: what is the optimal treatment?].

    abstract::Whole brain radiotherapy remains standard in the management of breast cancer patients with brain metastases. It allows for symptomatic improvement and good local control in most patients. However, its results remain suboptimal in terms of both efficacy and toxicity. In highly selected patients, stereotactic radiothera...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1335

    authors: Kirova YM,Chargari C,Mazeron JJ

    更新日期:2011-04-01 00:00:00

  • [Coordinated organization of symptoms management and support in all the stages of cancer disease: putting in place pluridisciplinary structures of supportive oncological care].

    abstract::The organization of the management of pain and other symptoms all along the cancer disease, of psychological support and palliative care is a complex question that does not correspond to any perfectly established model, both in France and abroad. Different structures are implied in there care and coexist with an insuf...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Krakowski I,Chardot C,Bey P,Guillemin F,Philip T

    更新日期:2001-03-01 00:00:00

  • [Role of interleukin 6 in hepatocellular carcinoma].

    abstract::Interleukin 6 (IL-6) is a pleiotropic cytokine which possesses a broad spectrum of action in diverse pathological conditions. It is mainly produced and metabolised in the liver where it carries out one of its best known actions in the mediation of the acute phase response. We studied its behaviour in hepatocellular ca...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Malaguarnera M,Di Fazio I,Laurino A,Romeo MA,Giugno I,Trovato BA

    更新日期:1996-05-01 00:00:00

  • [Major therapeutic advances in the treatment of metastatic melanoma].

    abstract::The treatment of metastatic melanoma is presently in complete revolution. Two molecules have recently been authorized for this indication. These treatments have a very different mechanism of action compared to previous chemotherapies. Vemurafenib is a targeted therapy, which blocks BRAF selectively. This molecule indu...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2012.1594

    authors: Mateus C,Robert C

    更新日期:2012-06-01 00:00:00

  • On the value of response criteria in therapeutic research.

    abstract::Primary chemotherapy is the use of anticancer drugs as the first treatment in patients with localized tumor presentations for which there is an alternative but less than satisfactory treatment. Its most important feature is the preservation of the primary tumor mass as a biologic marker of response, and in this sense ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Devita VT Jr

    更新日期:1988-01-01 00:00:00

  • [Hospital teaching of oncology].

    abstract::Theoretical teaching of oncology was improved, 15 years ago, by individualizing a special university course during medical studies in France. However medical students need also practical exercising by relation with cancer patients. The main goals may be defined and given to students at the beginning of practical cours...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hoerni B,Vrousos C

    更新日期:1985-01-01 00:00:00

  • [Thyroid carcinoma on struma ovarii: Diagnosis and treatment].

    abstract::Thyroid carcinoma on struma ovarii (TCSO) is a rare ovarian tumour, derivate from monodermic teratomas. It represents about 0.01% of overall ovarian tumours and 5 to 10% of struma ovarii. The diagnosis is histologic and retrospective after pelvic surgery; radiographic imaging being unspecific. Because of its rarity, t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2017.11.014

    authors: Lebreton C,Al Ghuzlan A,Floquet A,Kind M,Leboulleux S,Godbert Y

    更新日期:2018-03-01 00:00:00

  • [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].

    abstract::Receptor assays for both ER and PR in breast cancer specimens is used either to choose adjuvant therapy during the first treatment, or to choose hormone therapy for metastatic patients, or for the diagnosis of tumors. Whereas biochemical methods, either by radioligand or by monoclonal antibodies, have progressed over ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Goussard J

    更新日期:1996-12-01 00:00:00

  • [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].

    abstract::Seventy children (3.7 +/- 3.3 y) with definitely confirmed diagnosis of neuroblastoma had 115 whole body scans carried out 24 h after injection of 3.7 MBq/kg of I-123 mIBG (83 scans) or 0.7 MBq/kg of I-131 mIBG (17 scans) or 0.9 to 4.5 GBq of I-131 mIBG (15 post-therapeutic scans). The scans were interpreted as positi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lumbroso J,Guermazi F,Hartmann O,Coornaert S,Rabarison Y,Lemerle J,Parmentier C

    更新日期:1988-01-01 00:00:00

  • [Multidisciplinary treatment of soft tissue sarcomas: an improvement in prognosis (author's transl)].

    abstract::The results obtained in the treatment of 45 cases of soft tissue sarcomas are presented. All cases were reviewed and classified according to the modern criteria of malignancy. The treatment schedule comprised: (1) preoperative irradiation: 2 sessions of 6.50 Gy in 48 hours, target volume: whole limb segment; (2) surgi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Abbatucci JS,Boulier N,Mandard AM,de Ranieri J,Tanguy A,Chasle J

    更新日期:1981-01-01 00:00:00

  • [Cured after an intraocular tumor].

    abstract::We describe the psychological reactions after diagnosis and treatment of the malignant intraocular tumors: uveal melanoma and retinoblastoma. The chapter on uveal melanoma includes general consideration on the treatment of these tumors, the psychological effects on the patients, the professional and social problems, t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Desjardins L,Delage M,Lumbroso L,Levy C,Doz F

    更新日期:2001-11-01 00:00:00

  • [Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer].

    abstract::Endometrial cancer is a common cancer in older women and is often associated with comorbidities. Management of metastatic disease and/or relapse requires a multidisciplinary approach. Recent advances in the understanding of oncogenesis and molecular classification of endometrial cancers offer new therapeutic perspecti...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.bulcan.2020.06.006

    authors: Alexandre J,Le Frere-Belda MA,Prulhiere K,Treilleux I,Leary A,Pomel C,Chargari C,Ducassou A,Joly F,groupe ARCAGY-GINECO.

    更新日期:2020-10-01 00:00:00

  • [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic haematopoietic cell transplantation (allo-HCT) is a potentially curative option, in particular in the case of relapse after autologous stem cell transp...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2017.08.008

    authors: Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

    更新日期:2017-12-01 00:00:00

  • [Psychological implications of cancer. I. Psychological consequences of the disease].

    abstract::The psychological consequences of cancer are most frequently reactive and do not constitute a major psychiatric illness. Anxiety and depression are the two main psychological disorders which occur frequently but with variable intensity according to the type of disease, its course, as well as the individual and social ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Zittoun R,Ruszniewski M

    更新日期:1988-01-01 00:00:00

  • [Radiotherapy for sarcoma: hadrontherapy, for whom and what for?].

    abstract::The radiobiological properties of the hadrons (neutrons, protons, carbon ions) led to their therapeutic use in sarcomas, as a referent therapy or as an alternative to photon therapy. An extensive review of the literature has been conducted to assess the present indications and the perspectives for hadrontherapy. Compa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2010.1125

    authors: Pommier P,Sunyach MP,Hu Y,Amsalem E,Claude L,Moncort-Boulch D,Toutenu P,Balosso J

    更新日期:2010-06-01 00:00:00

  • [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].

    abstract::Twenty-five adult patients, 15 men and 10 women, with a median age of 49, and presenting with metastatic or locally advanced soft tissue sarcomas, have been treated with chemotherapy protocol combining cisplatinum, 100 mg/m2, vindesine, 4 mg/m2, and either adriamycin, 50 mg/m2 (APEL) (16 patients), or epirubicin, 100 ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Becouarn Y,Bui BN,Kerbrat P,Chauvergne J,Brunet R,Robert J

    更新日期:1987-01-01 00:00:00